Ignite Creation Date:
2025-12-24 @ 12:12 PM
Ignite Modification Date:
2026-01-11 @ 4:50 PM
Study NCT ID:
NCT01292161
Status:
COMPLETED
Last Update Posted:
2011-02-09
First Post:
2011-02-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Effects of Silybum Marianum on Treatment of Patients With Chronic Hepatitis C
Sponsor:
Isfahan University of Medical Sciences
Organization:
Study Overview
Official Title:
Study of Silymarin for Improving Hepatitis C
Status:
COMPLETED
Status Verified Date:
2006-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine the effects of silymarin on outcomes of patients with hepatitis C.
Detailed Description:
Silymarin has been claimed to have a beneficial effect in various types of liver injury, including alcoholic liver disease, drug and toxin induced hepatotoxicity, and acute and chronic viral hepatitis.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: